Prevalence of Fatigue in Head and Neck Cancer Survivors

Paolo Bossi, Patricia Di Pede, Mauro Guglielmo, Roberta Granata, Salvatore Alfieri, Nicola Alessandro Iacovelli, Ester Orlandi, Marco Guzzo, Roberto Bianchi, Letizia Ferella, Gabriele Infante, Rosalba Miceli, Lisa Licitra, Carla Ida Ripamonti

Research output: Contribution to journalArticle

Abstract

Introduction: In head and neck cancer (HNC) patients, fatigue is present throughout the course of treatment and during follow-up. There are limited data about the prevalence and factors associated with fatigue in HNC survivors. The objectives of this study were to assess the prevalence of fatigue and its interference with daily life activities and examine the association between fatigue and gender, age, primary tumour site, Human Papillomavirus (HPV) status, previous oncologic therapy, and time since end of treatment. Methods: Consecutive locally advanced HNC patients having completed curative treatment at least 1 year earlier and free of disease were asked to fill in the Brief Fatigue Inventory (BFI) questionnaire. Fatigue was categorized according to BFI average score as absent (0), mild (>0 to <4), moderate (≥4 to ≤6), and severe (>6 to ≤10). Results: From February 2015 to July 2016, 129 patients (median age = 60 years old; 67% male) were evaluated. Primary sites of cancer were oropharynx (46%, with 4/5 patients HPV positive), nasopharynx (22%), larynx/hypopharynx (14%), oral cavity (13%), and paranasal sinus or salivary gland (5%). Oncologic treatment was completed 12 to 96 months earlier (median = 34 months). Fatigue was reported as absent in 15% of the patients, mild in 67%, moderate in 11%, and severe in 7%. No association between BFI average score and the analyzed variables was identified. Discussion: Moderate and severe fatigue was reported in 18% of HNC survivors. Further research is needed to assess its causes and improve the management.

Original languageEnglish
Pages (from-to)413-419
Number of pages7
JournalAnnals of Otology, Rhinology and Laryngology
Volume128
Issue number5
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Head and Neck Neoplasms
Fatigue
Survivors
Equipment and Supplies
Oropharyngeal Neoplasms
Therapeutics
Hypopharynx
Nasopharynx
Paranasal Sinuses
Larynx
Salivary Glands
Mouth

Keywords

  • fatigue
  • head and neck neoplasms
  • patient reported outcome measures
  • quality of life
  • survivals

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Prevalence of Fatigue in Head and Neck Cancer Survivors. / Bossi, Paolo; Di Pede, Patricia; Guglielmo, Mauro; Granata, Roberta; Alfieri, Salvatore; Iacovelli, Nicola Alessandro; Orlandi, Ester; Guzzo, Marco; Bianchi, Roberto; Ferella, Letizia; Infante, Gabriele; Miceli, Rosalba; Licitra, Lisa; Ripamonti, Carla Ida.

In: Annals of Otology, Rhinology and Laryngology, Vol. 128, No. 5, 01.05.2019, p. 413-419.

Research output: Contribution to journalArticle

Bossi, Paolo ; Di Pede, Patricia ; Guglielmo, Mauro ; Granata, Roberta ; Alfieri, Salvatore ; Iacovelli, Nicola Alessandro ; Orlandi, Ester ; Guzzo, Marco ; Bianchi, Roberto ; Ferella, Letizia ; Infante, Gabriele ; Miceli, Rosalba ; Licitra, Lisa ; Ripamonti, Carla Ida. / Prevalence of Fatigue in Head and Neck Cancer Survivors. In: Annals of Otology, Rhinology and Laryngology. 2019 ; Vol. 128, No. 5. pp. 413-419.
@article{b2ce8c58cf464a46aee44fc1e55155e1,
title = "Prevalence of Fatigue in Head and Neck Cancer Survivors",
abstract = "Introduction: In head and neck cancer (HNC) patients, fatigue is present throughout the course of treatment and during follow-up. There are limited data about the prevalence and factors associated with fatigue in HNC survivors. The objectives of this study were to assess the prevalence of fatigue and its interference with daily life activities and examine the association between fatigue and gender, age, primary tumour site, Human Papillomavirus (HPV) status, previous oncologic therapy, and time since end of treatment. Methods: Consecutive locally advanced HNC patients having completed curative treatment at least 1 year earlier and free of disease were asked to fill in the Brief Fatigue Inventory (BFI) questionnaire. Fatigue was categorized according to BFI average score as absent (0), mild (>0 to <4), moderate (≥4 to ≤6), and severe (>6 to ≤10). Results: From February 2015 to July 2016, 129 patients (median age = 60 years old; 67{\%} male) were evaluated. Primary sites of cancer were oropharynx (46{\%}, with 4/5 patients HPV positive), nasopharynx (22{\%}), larynx/hypopharynx (14{\%}), oral cavity (13{\%}), and paranasal sinus or salivary gland (5{\%}). Oncologic treatment was completed 12 to 96 months earlier (median = 34 months). Fatigue was reported as absent in 15{\%} of the patients, mild in 67{\%}, moderate in 11{\%}, and severe in 7{\%}. No association between BFI average score and the analyzed variables was identified. Discussion: Moderate and severe fatigue was reported in 18{\%} of HNC survivors. Further research is needed to assess its causes and improve the management.",
keywords = "fatigue, head and neck neoplasms, patient reported outcome measures, quality of life, survivals",
author = "Paolo Bossi and {Di Pede}, Patricia and Mauro Guglielmo and Roberta Granata and Salvatore Alfieri and Iacovelli, {Nicola Alessandro} and Ester Orlandi and Marco Guzzo and Roberto Bianchi and Letizia Ferella and Gabriele Infante and Rosalba Miceli and Lisa Licitra and Ripamonti, {Carla Ida}",
year = "2019",
month = "5",
day = "1",
doi = "10.1177/0003489419826138",
language = "English",
volume = "128",
pages = "413--419",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "5",

}

TY - JOUR

T1 - Prevalence of Fatigue in Head and Neck Cancer Survivors

AU - Bossi, Paolo

AU - Di Pede, Patricia

AU - Guglielmo, Mauro

AU - Granata, Roberta

AU - Alfieri, Salvatore

AU - Iacovelli, Nicola Alessandro

AU - Orlandi, Ester

AU - Guzzo, Marco

AU - Bianchi, Roberto

AU - Ferella, Letizia

AU - Infante, Gabriele

AU - Miceli, Rosalba

AU - Licitra, Lisa

AU - Ripamonti, Carla Ida

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Introduction: In head and neck cancer (HNC) patients, fatigue is present throughout the course of treatment and during follow-up. There are limited data about the prevalence and factors associated with fatigue in HNC survivors. The objectives of this study were to assess the prevalence of fatigue and its interference with daily life activities and examine the association between fatigue and gender, age, primary tumour site, Human Papillomavirus (HPV) status, previous oncologic therapy, and time since end of treatment. Methods: Consecutive locally advanced HNC patients having completed curative treatment at least 1 year earlier and free of disease were asked to fill in the Brief Fatigue Inventory (BFI) questionnaire. Fatigue was categorized according to BFI average score as absent (0), mild (>0 to <4), moderate (≥4 to ≤6), and severe (>6 to ≤10). Results: From February 2015 to July 2016, 129 patients (median age = 60 years old; 67% male) were evaluated. Primary sites of cancer were oropharynx (46%, with 4/5 patients HPV positive), nasopharynx (22%), larynx/hypopharynx (14%), oral cavity (13%), and paranasal sinus or salivary gland (5%). Oncologic treatment was completed 12 to 96 months earlier (median = 34 months). Fatigue was reported as absent in 15% of the patients, mild in 67%, moderate in 11%, and severe in 7%. No association between BFI average score and the analyzed variables was identified. Discussion: Moderate and severe fatigue was reported in 18% of HNC survivors. Further research is needed to assess its causes and improve the management.

AB - Introduction: In head and neck cancer (HNC) patients, fatigue is present throughout the course of treatment and during follow-up. There are limited data about the prevalence and factors associated with fatigue in HNC survivors. The objectives of this study were to assess the prevalence of fatigue and its interference with daily life activities and examine the association between fatigue and gender, age, primary tumour site, Human Papillomavirus (HPV) status, previous oncologic therapy, and time since end of treatment. Methods: Consecutive locally advanced HNC patients having completed curative treatment at least 1 year earlier and free of disease were asked to fill in the Brief Fatigue Inventory (BFI) questionnaire. Fatigue was categorized according to BFI average score as absent (0), mild (>0 to <4), moderate (≥4 to ≤6), and severe (>6 to ≤10). Results: From February 2015 to July 2016, 129 patients (median age = 60 years old; 67% male) were evaluated. Primary sites of cancer were oropharynx (46%, with 4/5 patients HPV positive), nasopharynx (22%), larynx/hypopharynx (14%), oral cavity (13%), and paranasal sinus or salivary gland (5%). Oncologic treatment was completed 12 to 96 months earlier (median = 34 months). Fatigue was reported as absent in 15% of the patients, mild in 67%, moderate in 11%, and severe in 7%. No association between BFI average score and the analyzed variables was identified. Discussion: Moderate and severe fatigue was reported in 18% of HNC survivors. Further research is needed to assess its causes and improve the management.

KW - fatigue

KW - head and neck neoplasms

KW - patient reported outcome measures

KW - quality of life

KW - survivals

UR - http://www.scopus.com/inward/record.url?scp=85061210808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061210808&partnerID=8YFLogxK

U2 - 10.1177/0003489419826138

DO - 10.1177/0003489419826138

M3 - Article

C2 - 30700107

AN - SCOPUS:85061210808

VL - 128

SP - 413

EP - 419

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 5

ER -